Medicale Corp. (MCLE)
Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014
Balance Sheet Date2025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312021-Mar-312020-Dec-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q2-FY2021Q1-FY2021
Operating Cash Flow(6,457$)(2,021$)(4,530$)(10,000$)(15,509$)(9,288$)(10,602$)(27,706$)(12,240$)(8,240$)(5,418$)159$(3,575$)(7,914$)
Investing Cash Flow0$0$
Purchases of Property and Equipment0$0$
Financing Cash Flow6,457$2,021$4,371$10,000$15,509$9,288$10,602$27,706$12,240$8,240$27,475$7,914$
End Cash Position159$159$159$159$159$159$159$159$159$23,900$0$0$
Exchange Rate Effect
Dividends Paid
Unlevered Free Cash Flow(6,457$)(2,021$)(4,530$)(10,000$)(15,509$)(9,288$)(10,602$)(27,706$)(12,240$)(8,240$)(5,418$)159$(3,575$)(7,914$)